Similar articles

• Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. CON: "lifetime use" is an awfully long time.

  Loftus EV. Loftus EV. Am J Gastroenterol. 2005 Jul;100(7):1435-8. doi: 10.1111/j.1572-0241.2005.50622_2.x. Am J Gastroenterol. 2005. PMID: 15984960 Review. No abstract available.
• Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. A BALANCING VIEW: lifetime channeling of infliximab for crohn's disease.

  Hanauer SB. Hanauer SB. Am J Gastroenterol. 2005 Jul;100(7):1438-9. doi: 10.1111/j.1572-0241.2005.50622_3.x. Am J Gastroenterol. 2005. PMID: 15984961 No abstract available.
• Guidelines for treatment with infliximab for Crohn's disease.

  Hommes DW, Oldenburg B, van Bodegraven AA, van Hogezand RA, de Jong DJ, Romberg-Camps MJ, van der Woude J, Dijkstra G; Dutch Initiative on Crohn and Colitis (ICC). Hommes DW, et al. Neth J Med. 2006 Jul-Aug;64(7):219-29. Neth J Med. 2006. PMID: 16929083 Review.
• Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

  Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, Liu G, Travers S, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano R; REACH Study Group. Hyams J, et al. Gastroenterology. 2007 Mar;132(3):863-73; quiz 1165-6. doi: 10.1053/j.gastro.2006.12.003. Epub 2006 Dec 3. Gastroenterology. 2007. PMID: 17324398 Clinical Trial.
• [Indications and results of infliximab in Crohn's disease].

  Karoui S, Boubaker J, Filali A. Karoui S, et al. Tunis Med. 2004 Dec;82(12):1057-63. Tunis Med. 2004. PMID: 15822505 Review. French.